top of page
DGGT_Munich24_banner.jpg

PROGRAMME

The programme will be available shortly

Wednesday 6 March

12:00-13:00

Registration

13:00-14:30 

Session 1: Targeting delivery of RNA Therapeutics

Chair: Ernst Wagner, LMU, Munich

 

13:00-13:20  Olivia Merkel, LMU, Munich

INV01: 

13:20-13:40  Ulrich Lächelt, University of Wien

INV02:  

13:40-14:00  Achim Aigner, Leipzig Medical University

INV03: 

14:00-14:20  Christian Plank, Ethris

INV04: 

14:30-16:00 

Session 2: Inflammation therapeutics

Chair: Ulrike Prötzer, TUM, Munich

 

14:30-14:50  Stefan Engelhardt,LMU, Munich

INV05: 

14:50-15:10  Dorothea von Laer, Innsbruck Medical university

INV06: 

15:10-15:30  Emmanuelle Six, Inserm, Paris

INV07: 

15:30-16:00  Oral presentations from abstracts

16:00-16:30

Coffee Break

16:30-18:00 

Session 3: Novel concepts in editing

Chair: Julian Grünewald, TUM Münich

16:30-16:50 Toni Cathomen, University of Freiburg

INV08

16:50-17:10 Zoltan Ivics, PEI, Langen

INV09

17:10-17:30 Angelo Lombardo, SR Tiget, Milan

INV10

17:30-17:50 Frank Buchholz, Dresden University

INV 11

18:00-19:00 

Keynote

Chair: Zoltan Ivics, PEI, Langen

18:00-19:00 Laura Sepp-Lorenzina, Intellia

INV12

19:00-20:00 

Afterglow & posterwalk

20:30-

Get together and networking event

Wedneday

THURSDAY 7 March

9:00–10:30

Session 5: Editing cardiomyopathies 

Chair: Christian Kupatt, TUM, Munich

 

9:00-9:20  Julian Grünewald, TUM, Munich

INV13

9:20-9:40  Lars Steinmetz, Stanford Univeristy

INV14:  

9:40-10:00  Simone Lebek, University klinik Regensburg

INV15:  

10:00-10:20  Eric Olson, Southwestern University

INV16:  

10:30-11:00

Coffee

11:00-12:30 

Session 6: New preclinical and clinical cancer concepts

Chair: Roland Rad, TUM, Munich

 

11:00-11:20  Claudio Mussolino, University of Freiburg

INV17: 

11:20-11:40  Stephan Preuss, BioNtech

INV18: 

11:40-12:00  Ben Kleinstiver, Harvard University

INV19: 

12:00–12:30   Selected orals from abstracts

12:30-14:00

Lunch & posters

14:00-15:30 

Session 7: Cancer cell therapy

Chair: Dirk Nettlebeck, Heidelberg

 

14:00-14:20  Knut Elbers, Viratherapeutics

INV20: 

14:20-14:40  Perr Sonne Holm, Innsbruck

INV21: 

14:40-15:00  Guy Ungerechts, Heidelberg

INV22: 

15:00–15:20   Marion Subklewe, LMU, Munich

INV23:

15:30-16:00

Coffee break

16:00-17:30 

Session 8: Novel cell therapeutics

Chair: Frank Bassermann, TUM, Munich

 

16:00-16:20  Andrea Schmidts, TUM, Munich

INV24: 

16:20-16:40  Christine Spitzweg, LMU, Munich

INV25: 

16:40-17:00  Winfried Wels, Frankfurt

INV26: 

17:00-17:20  Evelyn Ullrich, Frankfurt

INV26: 

17:30-19:00

Afterglow & posterwalk

Thursday
Friday

FriDAY 8 March

9:00–10:30

Session 9: In vivo gene therapeutics

Chair: Stefan Kochanek, Ulm

 

9:00-9:20  Stylianos Michalakis, LMU, Munich

INV27

9:20-9:40  Tarik Bozoglu, TUM, Munich

INV28:  

9:40-10:00  Hildegard Büning, MHH

INV29:  

10:00-10:20  Dirk Grimm, Heidelberg

INV30:  

10:30-11:00

Coffee

11:00-12:00 

Session 10: Young investigator session

Chair: Hildegard Büning, TUM, Munich

 

11:00-12:30  4 talks selected from Abstract submissions and Paper of the quarter

12:00-13:30 

Session 11: Ethical considerations

Chair: Chris Baum, BIH

 

12:00-12:20  Klaus Tanner, Halle

INV31: 

14:20-14:40  Eva Winkler, Heidelberg

INV32: 

14:40-15:00  Christiane Woopen, Bonn

INV33: 

15:00–15:20   Silja Voeneky, Freiburg

INV34:

bottom of page